Pseudohypoparathyroidism and its various phenotypes: three sisters with three different clinical presentations
Abstract
Pseudohypoparathyroidism (PHP) is a heterogeneous group of hereditary disorders characterized by clinical and biological characteristics of resistance to parathyroid hormone (PTH) caused by impaired hormonal signalling via receptors that are coupled, through the α- subunit of the stimulatory G protein (Gsα). In some cases, resistance to other hormones (such as TSH, gonadotropins, GHRH and calcitonin) that have receptors coupled via Gsα is observed. A subset of patients with PHP are characterized by the variable expression of a collection of physical features, termed Albright hereditary osteodystrophy (AHO), which includes brachydactyly, rounded face, short stature, central obesity, subcutaneous ossifications, and variable degrees of mental retardation. These patients face a wide range of problems from early childhood to adulthood, which include potentially severe alterations in mineral metabolism, which could be associated with seizures; other endocrine deficiencies due to hormone resistance that lead to hypothyroidism, hypogonadism and GH deficiency; growth impairment independently of hormonal status; ectopic ossifications with potential severe limitation of mobility; skeletal issues and cognitive and psychomotor impairment.
Here we report three sisters affected by pseudohypoparathyroidism but with remarkably differences from each other in terms of phenotypic and clinical-auxological characteristics, a demonstration of how this disease is characterized by a very heterogeneous phenotype, even among patients carrying the same genetic alteration.
Keywords
Full Text:
PDFReferences
1. Mantovani, G. (2011). Pseudohypoparathyroidism: Diagnosis and Treatment. J Clin Endocrinol Metab, 96(10), 3020–3030. doi: 10.1210/jc.2011-1048.
2. Mantovani, G., Bastepe, M., Monk, D., De Sanctis, L., Thiele, S., Usardi, A., Ahmed, S.F., Bufo, R., Choplin, T., De Filippo, G., Devernois, G., Eggermann, T., Elli, F.M., Freson, K., García Ramirez, A., Germain-Lee, E.L., Groussin, L., Hamdy, N., Hanna, P., Hiort, O., Jüppner, H., Kamenický, P., Knight, N., Kottler, M.L., Le Norcy, E., Lecumberri, B., Levine, M.A., Mäkitie, O., Martin, R., Martos-Moreno, G.Á., Minagawa, M., Murray, P., Pereda, A., Pignolo, R., Rejnmark, L., Rodado, R., Rothenbuhler, A., Saraff, V., Shoemaker, A.H., Shore, E.M., Silve, C., Turan, S., Woods, P., Zillikens, M.C., Perez de Nanclares, G., Linglart, A. (2018). Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol, 14(8), 476-500. doi: 10.1038/s41574-018-0042-0.
3. Linglart, A., Levine, M.A., Jüppner, H. (2018). Pseudohypoparathyroidism. Endocrinol Metab Clin North Am, 47(4), 865-888. doi: 10.1016/j.ecl.2018.07.011.
4. De Nanclares, G.P., Fernandez-Rebollo, E., Santin, I., García-Cuartero, B., Gaztambide, S., Menendez, E., Morales, M.J., Pombo, M., Bilbao, J.R., Barros, F., Zazo, N., Ahrens, W., Juppner, H., Hiort, O., Castano, L., Bastepe, M. (2007). Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright hereditary osteodystrophy. J Clin Endocrinol Metab, (92), 2370–2373. doi: 10.1210/jc.2006-2287.
5. Mariot, V., Maupetit-Me´houas, S., Sinding, C., Kottler, M.L., Linglart, A. (2008). A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J Clin Endocrinol Metab, (93), 661–665. doi: 10.1210/jc.2007-0927.
6. Unluturk, U., Harmanci, A., Babaoglu, M., Yasar, U., Varli, K., Bastepe, M., Bayraktar, M. (2008). Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. Am J Med Sci, (336), 84–90. doi: 10.1097/MAJ.0b013e31815b218f.
7. Mantovani, G., De Sanctis, L., Barbieri, A.M., Elli, F.M., Bollati, V., Vaira, V., Labarile, P., Bondioni, S., Peverelli, E., Lania, A.G., Beck-Peccoz, P., Spada, A. (2010). Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab, (95), 651–658. doi: 10.1210/jc.2009-0176.
8. De Sanctis, L., Giachero, F., Mantovani, G., Weber, G., Salerno, M., Baroncelli, G.I., Elli, M.F., Matarazzo, P., Wasniewska, M., Mazzanti, L., Scirè, G., Tessaris, D. (2016). Genetic and epigenetic alterations in the GNAS locus and clinical consequences in Pseudohypoparathyroidism: Italian common healthcare pathways adoption. Ital J Pediatr, 42(1), 101. doi: 10.1186/s13052-016-0310-3.
9. Mantovani, G., Bastepe, M., Monk, D., De Sanctis, L., Thiele, S., Ahmed, S.F., Bufo, R., Choplin, T., De Filippo, G., Devernois, G., Eggermann, T., Elli, F.M., Garcia Ramirez, A., Germain-Lee, E.L., Groussin, L., Hamdy, N.A.T., Hanna, P., Hiort, O., Jüppner, H., Kamenický, P., Knight, N., Le Norcy, E., Lecumberri, B., Levine, M.A., Mäkitie, O., Martin, R., Martos-Moreno, G.Á., Minagawa, M., Murray, P., Pereda, A., Pignolo, R., Rejnmark, L., Rodado, R., Rothenbuhler, A., Saraff, V., Shoemaker, A.H., Shore, E.M., Silve, C., Turan, S., Woods, P., Zillikens, M.C., Perez de Nanclares, G., Linglart, A. (2020). Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool forPhysicians and Patients. Horm Res Paediatr, 93(3), 182-196. doi: 10.1159/000508985.
DOI: https://doi.org/10.13129/1828-6550/APMB.109.2.2021.CCS6
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Fabio Sippelli, Chiara Ferraloro, Giulia Visalli, Giulia Cafarella, Domenico Corica, Malgorzata Wasniewska

This work is licensed under a Creative Commons Attribution 4.0 International License.